CANCER AND IMMUNOTHERAPY
Alice Park's April 4 cover story on the growing promise of immunotherapy for treating cancer--and the challenges of its limited availability--"made me realize how fortunate I am," wrote Barbara Jo Sieber of Bradenton, Fla., who is currently involved in a trial for such a treatment. But Roger Stone of Kirkland, Wash., underscored the point that enrolling in a clinical trial, while a way to obtain new therapies, can be heartbreaking too, as patients can be suddenly removed from a trial if they no longer fit the study parameters. "[Patients in a trial] are a thing, a statistic to the drug company and the study doctors," he wrote. "I know there are doctors that do care ... But this is wrong."
Back in TIME
April 5, 1976
THE…
